$LAND

Landis+Gyr Capital Markets Day 2026

Landis+Gyr Group held a Capital Markets Day in New York, outlining a strategy and financial framework through FY2028. The company reorganized around two segments—Connected Platforms and Grid Intelligence—and cited a $3.9 billion backlog for revenue visibility. It confirmed targets including mid-single-digit revenue CAGR, gross margin >35%, and ~80% free-cash-flow conversion from adjusted EBITDA.

Original reporting
Published Jun 1, 2026, 7:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 7:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Landis+Gyr Capital Markets Day 2026 — source image
Decision brief

The 30-second read

$LANDBullishMed
01

Why it matters

The company provides multi-year quantitative targets (mid-single-digit revenue CAGR, >35% gross margin, faster EBITDA/EPS growth, and ~80% FCF conversion) plus a large backlog (~$3.9B) to support revenue visibility and cash generation.

02

Market read

Material for LAND as it updates the market on its multi-year growth and profitability framework and provides backlog visibility that can reset/anchor forward estimates.

03

What to watch

Backlog quality (timing, conversion to revenue, margin mix) and execution risk on new segment alignment could drive divergence from the stated CAGR/margin path.

Relevance 8/10Novelty 6/10Timing: Capital Markets Day update released pre-market (June 1, 2026)

Background

Landis+Gyr held a Capital Markets Day in New York to update strategy, technology roadmap, and financial framework, reorganizing around two segments: Connected Platforms and Grid Intelligence.

Company-level read

Ticker impact

$LANDBullishMedium confidence
Context

Landis+Gyr confirms mid-term growth expectations through FY2028 and introduces new Connected Platforms and Grid Intelligence segments at its CMD.

Expected impact

Moderately positive bias for near-term trading as guidance framework and backlog visibility support valuation and earnings expectations.

Evidence & confidence

The article is a company-issued CMD with specific quantitative targets and backlog figures, which typically moves forward expectations even without a new earnings print.

Market effects

Reinforces demand visibility in grid-edge technologies (metering/analytics/software/AI-enabled applications) and may support sentiment for utility tech infrastructure spend.

Primarily impacts US-listed sentiment for European grid technology providers; limited direct regional spillover beyond utilities/energy infrastructure investors.

Backlog and multi-year targets signal durability of grid modernization capex globally, potentially affecting peers’ read-across on contract visibility.

Counterpoint

CMD targets may already be priced; without incremental guidance beyond the framework, upside may be limited versus expectations.

Key entities

  • Landis+Gyr Group AG

    Subject of the CMD; confirms FY2028 growth/profitability framework and introduces new operating segments.

  • Peter Mainz

    CEO quoted on pipeline strength and backlog visibility supporting durable growth.

  • Davinder Athwal

    CFO quoted on disciplined operating model, margins, cash flow, and shareholder returns.

Related articles

$LANDMed

Gladstone Land (LAND) Q2 2026 Earnings Call Transcript

Gladstone Land (LAND) reported Q2 2026 revenues of $12.7M, up 3.2%, and a net loss of $13.5M due to a $4.2M impairment charge. Adjusted FFO improved to -$1.6M. The company issued $14.1M in shares, repurchased preferred stock, and reduced total indebtedness to $487.8M. Management highlighted higher almond and pistachio prices, water security efforts, and a shift to participation-based revenue.

$LANDMed

Gladstone Land Corporation: Gladstone Land Announces Second Quarter 2026 Results

Gladstone Land (Nasdaq:LAND) reported Q2 2026 results for the quarter ended June 30, 2026. Net loss was about $8.5M, and AFFO was about -$1.6M. Participation rents rose to about $201k from $142k, and it recorded a $4.2M non-cash impairment. The company entered a $37.0M farm credit facility, filed an SEC-effective $1.0B securities registration, and sold 1.38M shares under its ATM for ~$14.1M.

$LANDMed

Gladstone Land Corporation: Gladstone Land Announces Preferred Stock Repurchase Authorization

Gladstone Land (Nasdaq: LAND) said its board authorized repurchases of up to $20 million of its 6.00% Series B preferred stock (Nasdaq: LANDO) and up to $35 million of its 6.00% Series C preferred stock (Nasdaq: LANDP). Purchases may occur via open-market or negotiated transactions, subject to trading windows or Rule 10b5-1 plans. Authorization expires July 14, 2027.

$ROIVMedAI 8/10

What Lisraya’s $35,000 Monthly Price Could Mean for Roivant (ROIV)

Roivant Sciences (ROIV) and Priovant Therapeutics launched Lisraya, a $35,000/month dermatomyositis treatment, post-FDA approval. The drug's high price and small patient population present challenges, but its immediate launch and long exclusivity may drive adoption. ROIV owns 71% of Priovant, making Lisraya's success crucial for its financial outlook.

$BEMed

Bloom Energy (BE) Joins S&P 500: Can Its AI Rally Continue?

Bloom Energy (BE) will join the S&P 500 on September 21, effective before market open. The company's stock surged over 150% in 2026, driven by demand for its power solutions in AI data centers. Bloom Energy reported 166% revenue growth in Q2 and raised its full-year revenue outlook to $3.9B-$4.2B. The company has partnerships with Oracle and Brookfield Asset Management, aiming to accelerate fuel cell deployment.